World Asset Management Inc lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% in the second quarter, Holdings Channel.com reports. The firm owned 17,446 shares of the healthcare conglomerate’s stock after selling 802 shares during the period. UnitedHealth Group accounts for 0.6% of World Asset Management Inc’s investment portfolio, making the stock its 26th largest holding. World Asset Management Inc’s holdings in UnitedHealth Group were worth $6,986,000 at the end of the most recent quarter.
Several other large investors have also made changes to their positions in UNH. Fiera Capital Corp grew its position in UnitedHealth Group by 99.5% during the first quarter. Fiera Capital Corp now owns 2,137,018 shares of the healthcare conglomerate’s stock valued at $795,120,000 after acquiring an additional 1,065,868 shares during the period. Capital International Investors grew its position in UnitedHealth Group by 5.8% during the first quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock valued at $7,032,097,000 after acquiring an additional 1,040,094 shares during the period. Lazard Asset Management LLC grew its position in UnitedHealth Group by 185.4% during the first quarter. Lazard Asset Management LLC now owns 1,178,666 shares of the healthcare conglomerate’s stock valued at $438,545,000 after acquiring an additional 765,729 shares during the period. Ontario Teachers Pension Plan Board purchased a new stake in UnitedHealth Group during the first quarter valued at about $266,424,000. Finally, Franklin Resources Inc. grew its position in UnitedHealth Group by 15.3% during the first quarter. Franklin Resources Inc. now owns 3,944,677 shares of the healthcare conglomerate’s stock valued at $1,467,697,000 after acquiring an additional 522,460 shares during the period. 86.21% of the stock is owned by institutional investors and hedge funds.
UNH stock traded up $4.29 during trading on Wednesday, reaching $416.83. 47,377 shares of the stock were exchanged, compared to its average volume of 2,983,495. UnitedHealth Group Incorporated has a twelve month low of $289.64 and a twelve month high of $431.36. The company has a market capitalization of $393.04 billion, a P/E ratio of 27.25, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77. The stock has a 50 day simple moving average of $416.16 and a 200-day simple moving average of $398.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th will be paid a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date is Friday, September 10th. UnitedHealth Group’s dividend payout ratio is 34.36%.
Several equities research analysts have recently weighed in on the company. Oppenheimer reaffirmed a “buy” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 15th. Seaport Res Ptn reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 9th. Seaport Global Securities assumed coverage on UnitedHealth Group in a research report on Friday, July 9th. They issued a “buy” rating and a $450.00 target price for the company. Wells Fargo & Company assumed coverage on UnitedHealth Group in a research report on Monday, May 24th. They issued an “overweight” rating and a $478.00 target price for the company. Finally, Truist Securities upped their target price on UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a research report on Friday, July 16th. Three analysts have rated the stock with a hold rating, twenty have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $444.04.
In other news, Director Richard T. Burke sold 4,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, June 21st. The shares were sold at an average price of $398.62, for a total value of $1,594,480.00. Following the completion of the transaction, the director now owns 154,181 shares in the company, valued at $61,459,630.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stephen J. Hemsley sold 60,000 shares of the firm’s stock in a transaction that occurred on Friday, July 16th. The shares were sold at an average price of $420.62, for a total transaction of $25,237,200.00. Following the completion of the sale, the director now directly owns 941,560 shares of the company’s stock, valued at approximately $396,038,967.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 100,438 shares of company stock valued at $41,902,034. Corporate insiders own 0.55% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Story: How does the Beige Book influence monetary policy?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.